Standard care beneficial in many biologic-eligible asthma cases

Дата публикации: 16-10-2026 11:43:59

In the years after becoming eligible for biologic therapy, 70% of adults with severe asthma achieved a lower yearly rate of exacerbations with just standard care, according to data published in CHEST.“In patients with severe asthma and frequent exacerbations, review their blood eosinophil counts from previous years,” Freda Yang, MBChB, MD, honorary clinical senior lecturer at the National Heart and Lung Institute, Imperial College London, and consultant respiratory physician at Royal Brompton Hospital, told Healio.“Persistent eosinophilia suggests continued frequent exacerbations and a likely

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Biologics linked to fewer cardiovascular events in severe asthma	0	9.34	19-10-2026
2	Most patients with severe asthma switch or discontinue biologics	0	9.97	19-10-2026
3	Tezepelumab curbs asthma exacerbations across neutrophil counts	0	10.18	20-10-2026
4	Proton pump inhibitor use linked to exacerbations in asthma	0	7.22	20-10-2026
5	Quality of life improves in asthma with depemokimab	0	11.79	20-10-2026
6	Asthma ‘weekend effect’ due to poorer health upon admission	0	6.66	19-10-2026
7	Mortality odds lower with asthma, COPD in DKA hospitalization	0	11.39	26-10-2026
8	Black children at risk for severe form of asthma, new research shows	0	6.5	16-10-2026
9	'Enseñar' al cuerpo a bajar la inflamación, el hallazgo con firma española para ayudar a resolver el asma crónico	0	8.28	17-06-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 9.78. Источник: www.healio.com.